Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3, 3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554)-Reference-Cited by-同舟云学术

Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3, 3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554)

Published:1997-12 Issue:11 Volume:54 Page:1217-1224
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Aboagye Eric O.,Lewis Alexander D.,Tracy Michael,Workman Paul

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference38 articles.

1. The experimental development of bioreductive drugs and their role in cancer therapy;Workman;Cancer Metastasis Rev,1993

2. Sensitization of hypoxic cells—Clinical experience;Overgaard;Int J Radiat Biol,1989

3. Measurement of hypoxia in human tumours by non-invasive SPECT imaging of iodoazomycin arabinoside;Urtasun;Br J Cancer,1996

4. Imaging tumour hypoxia and tumour perfusion;Groshar;J Nucleic Med,1993

5. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole;Koh;Int J Radiat Oncol Biol Phys,1992

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET;Frontiers in Oncology;2021-09-07

2. Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2020-12

3. Molecular mechanisms of hypoxia in cancer;Clinical and Translational Imaging;2017-05-11

4. An effective tumor-targeting strategy utilizing hypoxia-sensitive siRNA delivery system for improved anti-tumor outcome;Acta Biomaterialia;2016-10

5. Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs;Cancer Research;2015-08-21